US 11446238
Injectable dendrimer hydrogel nanoparticles
granted A61KA61K31/43A61K47/595
Quick answer
US patent 11446238 (Injectable dendrimer hydrogel nanoparticles) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/43, A61K47/595, A61K47/6903, A61K9/0019